Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7601 USD | +2.03% | +7.37% | -84.50% |
03-15 | Maxim Group Adjusts Quoin Pharmaceuticals Price Target to $4 From $15, Maintains Buy Rating | MT |
03-14 | Quoin Pharmaceuticals Seeks M&A Opportunities | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-84.50% | 2.75M | |
+20.48% | 46.81B | |
-0.99% | 41.37B | |
+47.02% | 41.29B | |
-6.20% | 28.87B | |
+10.65% | 26.06B | |
-20.86% | 19.13B | |
+32.00% | 12.39B | |
+0.21% | 12.08B | |
+0.01% | 11.96B |
- Stock Market
- Equities
- QNRX Stock
- News Quoin Pharmaceuticals, Ltd.
- Maxim Starts Quoin Pharmaceuticals at Buy with $5 Price Target